GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

RBC Life Sciences RBCL · USD

Consumer Staples · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2016

Revenue

$25.8m

FY2014FY2016

Net income

−$756,284

FY2014FY2016

Free cash flow

$6,698

FY2014FY2016

Shareholders' equity

$7.1m

FY2014FY2016

Income statement

Fiscal years

FY2016FY2015FY2014
Revenue$25.8m$24.4m$28.3m
Gross profit$13.6m$13.5m$15.6m
Operating income−$666,283−$2.5m−$625,266
Net income−$756,284−$741,839−$602,811
Diluted earnings per share-0.34-0.34-0.27

Balance sheet

At each fiscal year end

FY2016FY2015FY2014
Total assets$11.0m$11.3m$16.0m
Cash and short-term investments$1.5m$1.4m$1.9m
Total liabilities$3.8m$3.4m$7.6m
Debt——$1.1m
Shareholders' equity$7.1m$7.9m$8.4m
Shares outstanding2m2m2m

Cash flow

Fiscal years

FY2016FY2015FY2014
Cash from operations$155,534−$4.3m−$607,732
Capital spending−$148,836−$179,950−$1.1m
Free cash flow$6,698−$4.4m−$1.7m

Latest quarters

By quarter end

Sept 2017Jun 2017Mar 2017Dec 2016Sept 2016Jun 2016Mar 2016Dec 2015
Revenue$4.9m$5.7m$5.7m$7.3m$7.3m$6.0m$5.2m$7.4m
Gross profit$2.5m$3.2m$3.0m$3.6m$3.9m$3.3m$2.7m$3.8m
Operating income−$356,799−$176,000−$39,361−$217,688$294,034−$219,383−$523,246−$2.0m
Net income−$350,413−$114,968$45,850−$270,754$106,647−$182,967−$409,210−$276,970
Diluted earnings per share-0.16-0.050.02-0.120.05-0.08-0.18-0.13
Total assets$11.9m$12.3m$11.5m$11.0m$11.2m$11.3m$10.9m$11.3m
Cash and short-term investments$685,431$727,290$650,379$1.5m$1.3m$786,528$757,603$1.4m
Shareholders' equity$6.6m$6.9m$7.0m$7.1m$7.3m$7.2m$7.4m$7.9m

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return757%-30%-98%4233%-94%2276%429%4828%32%175%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 7-to-1 reverse split · 17 Apr 1997

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.